New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta) - PubMed (original) (raw)
. 1999 Nov 1;160(3):238-49.
doi: 10.1006/taap.1999.8770.
Affiliations
- PMID: 10544058
- DOI: 10.1006/taap.1999.8770
New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta)
A Lampen et al. Toxicol Appl Pharmacol. 1999.
Abstract
Therapy with the antiepileptic drug valproic acid (2-propylpentanoic acid, VPA) during early pregnancy can cause teratogenic effects (neural tube defects) in humans and in mice. VPA and a teratogenic derivative specifically induce differentiation of F9 teratocarcinoma cells and activate PPARdelta. We have now studied structure-activity relationships of 11 VPA-related compounds by quantitatively comparing their teratogenic potency with their effects in the two novel in vitro systems. Based on the induction of a Rous sarcoma virus (RSV) promoter-driven reporter gene, which is associated with the differentiation of F9 cells, a system suitable for high-throughput and quantitative screening was established. Structure-activity investigations showed that only teratogenic derivatives of VPA induced the response in F9 cells as well as activated the PPARdelta-dependent reporter system in Chinese hamster ovary (CHO) cells. Increases in the length of the side chain in the VPA-related 2-alkyl-pentynoic acid generate more potent inducers in the cell-culture-based assays, which also show higher teratogenicity and embryonic lethality rates. Activation of PPARdelta correlated well with the effects in the F9 cell assay and with teratogenic potency in vivo (p < 0.007). Evaluation of the effects of the presented set of compounds allows the conclusion that the in vitro systems faithfully reflect teratogenicity of VPA-related compounds. Whether the activation of PPARdelta is causally related to the disruption of proper embryonic development or whether it reflects other yet unknown VPA-induced events remains to be established.
Copyright 1999 Academic Press.
Similar articles
- Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A, Göttlicher M, Nau H. Lampen A, et al. ALTEX. 2001;18(2):123-6. ALTEX. 2001. PMID: 11378687 - Induction of differentiation in F9 cells and activation of peroxisome proliferator-activated receptor delta by valproic acid and its teratogenic derivatives.
Werling U, Siehler S, Litfin M, Nau H, Göttlicher M. Werling U, et al. Mol Pharmacol. 2001 May;59(5):1269-76. doi: 10.1124/mol.59.5.1269. Mol Pharmacol. 2001. PMID: 11306712 - Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A. Ornoy A. Reprod Toxicol. 2009 Jul;28(1):1-10. doi: 10.1016/j.reprotox.2009.02.014. Epub 2009 Mar 13. Reprod Toxicol. 2009. PMID: 19490988 Review. - Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
de Jong E, Doedée AM, Reis-Fernandes MA, Nau H, Piersma AH. de Jong E, et al. Reprod Toxicol. 2011 May;31(4):375-82. doi: 10.1016/j.reprotox.2010.11.012. Epub 2010 Nov 27. Reprod Toxicol. 2011. PMID: 21115111 Review.
Cited by
- Valproic acid disrupts the biomechanics of late spinal neural tube closure in mouse embryos.
Hughes A, Greene NDE, Copp AJ, Galea GL. Hughes A, et al. Mech Dev. 2018 Feb;149:20-26. doi: 10.1016/j.mod.2017.12.001. Epub 2017 Dec 7. Mech Dev. 2018. PMID: 29225143 Free PMC article. - Recent advances in Duchenne muscular dystrophy.
Perkins KJ, Davies KE. Perkins KJ, et al. Degener Neurol Neuromuscul Dis. 2012 Oct 11;2:141-164. doi: 10.2147/DNND.S26637. eCollection 2012. Degener Neurol Neuromuscul Dis. 2012. PMID: 30890885 Free PMC article. Review. - Mood stabilizer psychopharmacology.
Gould TD, Chen G, Manji HK. Gould TD, et al. Clin Neurosci Res. 2002 Dec;2(3-4):193-212. doi: 10.1016/S1566-2772(02)00044-0. Epub 2002 Nov 14. Clin Neurosci Res. 2002. PMID: 22707923 Free PMC article. - Valproic acid protects against haemorrhagic shock-induced signalling changes via PPARγ activation in an in vitro model.
Zuckermann AM, La Ragione RM, Baines DL, Williams RS. Zuckermann AM, et al. Br J Pharmacol. 2015 Nov;172(22):5306-17. doi: 10.1111/bph.13320. Epub 2015 Oct 22. Br J Pharmacol. 2015. PMID: 26333042 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous